Real life use of talimogene laherparepvec in melanoma in centers in Austria and Switzerland

C Hoeller; JM Ressler; M Karasek; VA Lopez; L Koch; H Kehrer; P Koelblinger; F Weihsengruber; J Kofler; E Richtig; OA Michielin; C Hafner

Real life use of talimogene laherparepvec in melanoma in centers in Austria and Switzerland

C Hoeller, JM Ressler, M Karasek, VA Lopez, L Koch, H Kehrer, P Koelblinger, F Weihsengruber, J Kofler, E Richtig, OA Michielin, C Hafner

Department of Dermatology and Allergology

Research output: Contribution to journal › Abstract (Journal) › peer-review

2 Citations (Web of Science)

Original language	English
Pages (from-to)	548-+
Journal	ANNALS OF ONCOLOGY
Volume	30
Publication status	Published - 2019
Event	44th Congress of the European-Society-for-Medical-Oncology (ESMO) - Barcelona, SPAIN Duration: 27 Sept 2019 → 1 Oct 2019

Cite this

Hoeller, C., Ressler, JM., Karasek, M., Lopez, VA., Koch, L., Kehrer, H., Koelblinger, P., Weihsengruber, F., Kofler, J., Richtig, E., Michielin, OA., & Hafner, C. (2019). Real life use of talimogene laherparepvec in melanoma in centers in Austria and Switzerland. ANNALS OF ONCOLOGY , 30, 548-+.

Hoeller, C ; Ressler, JM ; Karasek, M et al. / Real life use of talimogene laherparepvec in melanoma in centers in Austria and Switzerland. In: ANNALS OF ONCOLOGY 2019 ; Vol. 30. pp. 548-+.

@article{65cbdda2f846411b9a5211787793b454,

title = "Real life use of talimogene laherparepvec in melanoma in centers in Austria and Switzerland",

author = "C Hoeller and JM Ressler and M Karasek and VA Lopez and L Koch and H Kehrer and P Koelblinger and F Weihsengruber and J Kofler and E Richtig and OA Michielin and C Hafner",

year = "2019",

language = "English",

volume = "30",

pages = "548--+",

journal = "ANNALS OF ONCOLOGY ",

issn = "0923-7534",

publisher = "Elsevier ",

note = "44th Congress of the European-Society-for-Medical-Oncology (ESMO) ; Conference date: 27-09-2019 Through 01-10-2019",

}

Hoeller, C, Ressler, JM, Karasek, M, Lopez, VA, Koch, L, Kehrer, H, Koelblinger, P, Weihsengruber, F, Kofler, J, Richtig, E, Michielin, OA & Hafner, C 2019, 'Real life use of talimogene laherparepvec in melanoma in centers in Austria and Switzerland', ANNALS OF ONCOLOGY , vol. 30, pp. 548-+.

Real life use of talimogene laherparepvec in melanoma in centers in Austria and Switzerland. / Hoeller, C; Ressler, JM; Karasek, M et al.
In: ANNALS OF ONCOLOGY , Vol. 30, 2019, p. 548-+.

Research output: Contribution to journal › Abstract (Journal) › peer-review

TY - JOUR

T1 - Real life use of talimogene laherparepvec in melanoma in centers in Austria and Switzerland

AU - Hoeller, C

AU - Ressler, JM

AU - Karasek, M

AU - Lopez, VA

AU - Koch, L

AU - Kehrer, H

AU - Koelblinger, P

AU - Weihsengruber, F

AU - Kofler, J

AU - Richtig, E

AU - Michielin, OA

AU - Hafner, C

PY - 2019

Y1 - 2019

M3 - Abstract (Journal)

SN - 0923-7534

VL - 30

SP - 548-+

JO - ANNALS OF ONCOLOGY

JF - ANNALS OF ONCOLOGY

T2 - 44th Congress of the European-Society-for-Medical-Oncology (ESMO)

Y2 - 27 September 2019 through 1 October 2019

ER -

Hoeller C, Ressler JM, Karasek M, Lopez VA, Koch L, Kehrer H et al. Real life use of talimogene laherparepvec in melanoma in centers in Austria and Switzerland. ANNALS OF ONCOLOGY . 2019;30:548-+.